New Zealand markets closed
  • NZX 50

    11,112.16
    -28.91 (-0.26%)
     
  • NZD/USD

    0.6176
    +0.0025 (+0.41%)
     
  • ALL ORDS

    6,836.90
    +52.60 (+0.78%)
     
  • OIL

    98.32
    -0.21 (-0.21%)
     
  • GOLD

    1,740.00
    +3.50 (+0.20%)
     

Intracranial Stents Global Market Report 2022

·4-min read
ReportLinker
ReportLinker

Major players in the intracranial stents market are Medtronic, Balt, Stryker Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, Acandis GmbH, Admedes Schuessler GmbH, MicroVention (Terumo), and Phenox.

New York, May 25, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Intracranial Stents Global Market Report 2022" - https://www.reportlinker.com/p06280878/?utm_source=GNW


The global intracranial stents market is expected to grow from $0.31 billion in 2021 to $0.36 billion in 2022 at a compound annual growth rate (CAGR) of 16.4%. The market is expected to grow to $0.7 billion in 2026 at a compound annual growth rate (CAGR) of 17.8%.

The intracranial stents market consists of sales of intracranial stents by entities (organizations, sole traders, and partnerships) that manufacture intracranial stents.Intracranial stents are the tubular device that is placed inside the blood vessel, canal, or duct.

They are used for intracranial stenosis and brain aneurysms to open the blocked arteries.

The main types of intracranial stents are self-expanding stents, balloon expanding stents, and stent-assisted coil embolization.A self-expanding stent expands on its own after being inserted into the lumen it is meant to occupy, such as a blood vessel, tube, or organ.

Balloon expanding stents also known as balloon-expandable stents have higher radial stiffness and more accurate placement and are designed to treat restenosis in the iliac artery by opening clogged arteries and restoring blood flow.Stent-assisted coil embolization helps stabilize the coils within the aneurysm and provides a buttress that allows for coil deposition while preventing coil herniation into the parent vessel lumen.

The various indications of diseases include brain aneurysm, intracranial stenosis and are implemented in various sectors such as hospitals, ambulatory surgery centers, others.

The increasing incidence of a brain aneurysm is expected to propel the growth of the intracranial stents market in the coming years.A brain aneurysm is the development of a bulge in the blood vessels of the brain.

This bulge may rupture or burst and can cause brain hemorrhage, which may lead to the death of the patient.Intracranial vessel stenting (IVS) is a minimally invasive treatment for treating serious cerebral artery stenosis.

The weakening of the arteries that deliver blood to the brain is known as cerebral artery stenosis. According to the brain aneurysm foundation, 2020, an expected 6.5 million people in the USA are suffering from an unruptured brain aneurysm, accounting for about one in every 50 people. Additionally, a brain aneurysm causes around 500,000 deaths globally every year and is more common among women. Thus, the increasing incidence of a brain aneurysm will drive the intracranial stents market growth.

The introduction of flow diversion technology to the field of neuro interventions has revolutionized the treatment of intracranial aneurysms which is a key trend gaining popularity in the intracranial stents market.Flow diversion is an endovascular procedure in which a device is inserted in the parent blood vessel to move blood flow away from the aneurysm rather than around the aneurysm sac.

For instance, in March 2020, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) developed an innovative intracranial flow diverter stent for brain aneurysms treatment.Intracranial flow diverters have the benefit of becoming adaptable and flexible to the vessel’s shape and direction and also help the vessel wall recover by relieving it of the continuous burden of blood flow.

It is entitled as Chitra flow diverter, the device is ready for transfer and further testing in animals to be followed by human trials.

In January 2021, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), an autonomous institute of the Department of Science & Technology (DST), Govt of India, under the Technical Research Centre (TRC), announced that it has entered into Technology Transfer Agreements with Biorad Medisys, for two biomedical implant devices namely an Atrial Septal Defect Occluder and an Intracranial Flow Diverter Stents developed by the institute in collaboration with National Aerospace Laboratories, Bangalore (CSIR-NAL)using superelastic NiTiNOL alloys. Biorad Medisys is an India based company that manufactures various implants and surgical devices

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the intracranial stents market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.


Read the full report: https://www.reportlinker.com/p06280878/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting